143 related articles for article (PubMed ID: 15645696)
21. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
[TBL] [Abstract][Full Text] [Related]
22. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides.
Rehfeld JF
Acta Physiol (Oxf); 2011 Apr; 201(4):405-11. PubMed ID: 21392266
[TBL] [Abstract][Full Text] [Related]
23. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
24. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.
Enç FY; Ones T; Akin HL; Dede F; Turoğlu HT; Ulfer G; Bekiroğlu N; Haklar G; Rehfeld JF; Holst JJ; Ulusoy NB; Imeryüz N
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G482-9. PubMed ID: 19109408
[TBL] [Abstract][Full Text] [Related]
25. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
[TBL] [Abstract][Full Text] [Related]
26. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
27. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
[TBL] [Abstract][Full Text] [Related]
28. Physiological mechanisms mediating aspartame-induced satiety.
Hall WL; Millward DJ; Rogers PJ; Morgan LM
Physiol Behav; 2003 Apr; 78(4-5):557-62. PubMed ID: 12782208
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.
Elliott RM; Morgan LM; Tredger JA; Deacon S; Wright J; Marks V
J Endocrinol; 1993 Jul; 138(1):159-66. PubMed ID: 7852887
[TBL] [Abstract][Full Text] [Related]
30. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
31. [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
Diamant M; Bunck MC; Heine RJ
Ned Tijdschr Geneeskd; 2004 Sep; 148(39):1912-7. PubMed ID: 15495988
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
33. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
34. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
35. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides.
Herrmann-Rinke C; Vöge A; Hess M; Göke B
J Endocrinol; 1995 Oct; 147(1):25-31. PubMed ID: 7490533
[TBL] [Abstract][Full Text] [Related]
36. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.
Näslund E; Gutniak M; Skogar S; Rössner S; Hellström PM
Am J Clin Nutr; 1998 Sep; 68(3):525-30. PubMed ID: 9734726
[TBL] [Abstract][Full Text] [Related]
38. Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
Müller M; Xu C; Navarro M; Masiques NE; Tilbrook A; van Barneveld R; Roura E
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37233611
[TBL] [Abstract][Full Text] [Related]
39. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
40. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V
Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
